Welch Financial Planning’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$589K Buy
2,252
+9
+0.4% +$2.31K 0.33% 40
2026
Q2
$564K Sell
2,243
-83
-4% -$17.9K 0.33% 41
2026
Q1
$506K Buy
2,326
+419
+22% +$92.9K 0.36% 39
2025
Q4
$436K Buy
+1,907
New +$434K 0.32% 42

Other funds holding ABBV

Welch Financial Planning's ABBV Position: Q3 2026 in Review

Welch Financial Planning increased its AbbVie (ABBV) stake by 0.4% in Q3 2026, buying an estimated $2.31K and bringing the position to 2,252 shares worth $589K. The position accounts for 0.33% of the portfolio, ranked #40.

Welch Financial Planning first reported a position in ABBV in Q4 2025 and has held it in 4 quarters since. 4,279 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Welch Financial Planning held 2,252 shares of AbbVie worth $589K as of Q3 2026.
  • Welch Financial Planning bought 9 AbbVie shares in Q3 2026, an estimated $2.31K.
  • AbbVie made up 0.33% of Welch Financial Planning's portfolio in Q3 2026, its #40 holding.
  • Welch Financial Planning first reported a position in AbbVie in Q4 2025 and has held it in 4 quarters since.
  • 4,279 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Welch Financial Planning's 13F filing for Q3 2026, filed 6 Nov 2026.